Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115336 · ClinicalTrials.gov registry record · Phase 4
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT00115336 is a Phase 4 study that was terminated before completion, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 10 participants.
The verdict
NCT00115336, a Phase 4 study, was terminated before completion, sponsored by Children's Hospital Medical Center, Cincinnati.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to compare ketorolac, a potent, non-steroidal anti-inflammatory drug (NSAID), with ibuprofen, a commonly used NSAID, for the treatment of the painful crisis of sickle cell disease (SCD).
Interventions
- DRUG Ibuprofen
- DRUG Intravenous Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00115336
The ClinicalTrials.gov registry entry for NCT00115336 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT00115336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00115336 about?
NCT00115336 is a clinical study titled "Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease". The purpose of this study is to compare ketorolac, a potent, non-steroidal anti-inflammatory drug (NSAID), with ibuprofen, a commonly used NSAID, for the treatment of the painful crisis of sickle cell disease (SCD).
What is the current status of trial NCT00115336?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2005-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00115336?
The interventions under investigation include: Ibuprofen (DRUG), Intravenous Ketorolac (DRUG).
Who is sponsoring clinical trial NCT00115336?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.